PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNϒ-drive acquired resistance in preclinical cancer models

Chun Wai Wong, Christos Evangelou, Kieran N. Sefton, Rotem Leshem, Wei Zhang, Vishaka Gopalan, Sorayut Chattrakarn, Macarena Lucia Fernandez Carro, Erez Uzuner, Holly Mole, Daniel J. Wilcock, Michael P. Smith, Kleita Sergiou, Brian a. Telfer, Dervla T. Isaac, Chang Liu, Nicholas R. Perl, Kerrie Marie, Paul Lorigan, Kaye J. WilliamsPatricia E. Rao, Raghavendar T. Nagaraju, Mario Niepel, Adam F. L. Hurlstone

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNϒ-drive acquired resistance in preclinical cancer models'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science